NYSE:NUVB Nuvation Bio Q2 2026 Earnings Report $6.33 -0.37 (-5.58%) Closing price 07/31/2026 03:59 PM EasternExtended Trading$6.33 +0.00 (+0.06%) As of 07/31/2026 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Nuvation Bio EPS ResultsActual EPSN/AConsensus EPS -$0.14Beat/MissN/AOne Year Ago EPSN/ANuvation Bio Revenue ResultsActual RevenueN/AExpected Revenue$27.03 millionBeat/MissN/AYoY Revenue GrowthN/ANuvation Bio Announcement DetailsQuarterQ2 2026Date8/6/2026TimeAfter Market ClosesConference Call DateThursday, August 6, 2026Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Nuvation Bio Earnings HeadlinesQ2 EPS Estimates for Nuvation Bio Raised by HC WainwrightJuly 31 at 1:12 AM | americanbankingnews.comNuvation Bio (NYSE:NUVB) Stock Price Expected to Rise, HC Wainwright Analyst SaysJuly 29, 2026 | americanbankingnews.comA New Gold Era Is Coming - Here's How to Help Protect Your Retirement NowWashington insiders are quietly talking about a coordinated move to revalue gold—and with the national debt approaching $39 trillion and gold near all-time highs, the window to position yourself ahead of it may be closing fast. Preserve Gold is offering a free guide that walks you through how to roll over your 401(k) or IRA into a Precious Metals IRA, tax and penalty-free, with up to $15,000 in free gold or silver for qualifying accounts.August 2 at 1:00 AM | Preserve Gold (Ad)Wedbush Reaffirms "Outperform" Rating for Nuvation Bio (NYSE:NUVB)July 25, 2026 | americanbankingnews.comNuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026July 22, 2026 | prnewswire.comAnalysts Set Nuvation Bio Inc. (NYSE:NUVB) PT at $12.38July 22, 2026 | americanbankingnews.comSee More Nuvation Bio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Nuvation Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nuvation Bio and other key companies, straight to your email. Email Address About Nuvation BioNuvation Bio (NYSE:NUVB) is a clinical-stage biotechnology company dedicated to discovering and developing small-molecule therapies for patients with cancer. The company employs an integrated research and development platform that spans target identification, preclinical evaluation, process chemistry, and early-stage clinical trials. By centralizing these capabilities, Nuvation Bio aims to accelerate the translation of promising drug candidates from laboratory research to first-in-human studies. The company’s pipeline comprises multiple oncology programs, with small-molecule kinase inhibitors and targeted agents in Phase 1 development for both hematologic malignancies and solid tumors. Nuvation Bio emphasizes a translational science approach, using biomarker strategies and patient-selection criteria to guide trial design and optimize the likelihood of clinical success. Its scientists leverage process chemistry expertise to streamline manufacturing and ensure scalable drug supply. Headquartered in New York, Nuvation Bio conducts global development activities through collaborations with leading academic centers, clinical research organizations, and commercial partners. The company’s leadership team brings extensive experience in drug discovery, translational research, and clinical development from both large pharmaceutical companies and emerging biotechnology firms. Adopting a capital-efficient operating model, Nuvation Bio balances in-house capabilities with strategic outsourcing to manage costs and accelerate timelines. With its focused pipeline and integrated development infrastructure, the company seeks to address critical unmet needs in oncology and advance novel therapies that have the potential to improve patient outcomes.View Nuvation Bio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 07/27- 07/31Chevron’s Strong Quarter Shows Why It Still Leads the Energy SectorNetflix's Big Sell-Off May Be Sending the Wrong SignalAmazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull CaseApple’s Record Quarter Could Not Outrun Its Guidance ProblemPopular’s Earnings Beat Shows Why This Bank Stock Keeps ClimbingMicrosoft Just Flipped the AI Spending Narrative Overnight Upcoming Earnings Booking (8/3/2026)Marriott International (8/3/2026)Diamondback Energy (8/3/2026)ONEOK (8/3/2026)Williams Companies (8/3/2026)Mitsubishi UFJ Financial Group (8/3/2026)Vertex Pharmaceuticals (8/3/2026)Palantir Technologies (8/3/2026)Spotify Technology (8/4/2026)SpaceX (8/4/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
